Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1999 2
2000 5
2001 4
2002 3
2004 7
2005 6
2006 3
2007 4
2008 3
2009 6
2010 7
2011 14
2012 8
2013 12
2014 9
2015 4
2016 8
2017 9
2018 12
2019 7
2020 7
2021 6
2022 10
2023 11
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Current drug targets for the critically ill COPD patient.
Makris D, Zakynthinos E. Makris D, et al. Among authors: zakynthinos e. Curr Drug Targets. 2011 Apr;12(4):447-9. doi: 10.2174/138945011794751564. Curr Drug Targets. 2011. PMID: 21194410 No abstract available.
Colistin Effects on Emphysematous Lung in an LPS-Sepsis Model.
Stamatiou R, Vasilaki A, Tzini D, Deskata K, Zacharouli K, Ioannou M, Sgantzos M, Zakynthinos E, Makris D. Stamatiou R, et al. Among authors: zakynthinos e. Antibiotics (Basel). 2023 Dec 14;12(12):1731. doi: 10.3390/antibiotics12121731. Antibiotics (Basel). 2023. PMID: 38136765 Free PMC article.
Inhaled antibiotics for nosocomial pneumonia.
Karvouniaris M, Makris D, Triantaris A, Zakynthinos E. Karvouniaris M, et al. Among authors: zakynthinos e. Inflamm Allergy Drug Targets. 2012 Apr;11(2):116-23. doi: 10.2174/187152812800392850. Inflamm Allergy Drug Targets. 2012. PMID: 22280234 Review.
Pulmonary embolism: pathophysiology, diagnosis, treatment.
Kostadima E, Zakynthinos E. Kostadima E, et al. Among authors: zakynthinos e. Hellenic J Cardiol. 2007 Mar-Apr;48(2):94-107. Hellenic J Cardiol. 2007. PMID: 17489347 Free article. Review. No abstract available.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Chastre J, François B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt CE, Sánchez-García M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Jafri HS; COMBACTE-MAGNET EVADE Study Group. Chastre J, et al. Crit Care. 2022 Nov 15;26(1):355. doi: 10.1186/s13054-022-04204-9. Crit Care. 2022. PMID: 36380312 Free PMC article. Clinical Trial.
Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant Klebsiella pneumonia.
Mantzarlis K, Manoulakas E, Parisi K, Sdroulia E, Zapaniotis N, Tsolaki V, Zakynthinos E, Makris D. Mantzarlis K, et al. Among authors: zakynthinos e. Antibiotics (Basel). 2024 Jan 31;13(2):141. doi: 10.3390/antibiotics13020141. Antibiotics (Basel). 2024. PMID: 38391527 Free PMC article.
161 results